SFL NSE filing

Sheela Foam Limited Q2 FY'26 Earnings Conference Call Transcript

The RealCase readMedium impact Neutral

Sheela Foam releases transcript of investor call for quarter ended September 30, 2025. Reports 5% Y-o-Y revenue growth; EBITDA up 31%. Kurlon merger complete.

Why it matters

The announcement provides insights into the company's financial performance, strategic initiatives, and future outlook, which can influence investor sentiment and stock valuation.

The market read

The announcement is a release of the transcript of the conference call and contains factual information about the company's financial performance, growth, and future plans.

* Transcript of the Investors’ conference call for the quarter and half-year ended September 30, 2025, has been released. * The conference call was held on November 06, 2025. * Rahul Gautam, Executive Chairman and Managing Director, mentioned that the merger of Kurlon with Sheela Foam is complete, effective from October 20, 2023. * The company recorded core EBITDA margins above 10% on a consolidated basis for both the quarter and half-year. * Mattress business grew by 13%, and the foam business grew by 9% in Q2 FY'26. * Sleepwell grew by 14%, while Kurlon grew by 13% within the mattress business. * The company expects to add a similar number of 420 showrooms in the second half of the year, totaling 800 by year-end. * Furlenco added more than 34,000 net customers in H1 FY'26 and achieved a PAT of ₹9 crore, with a revenue run rate above ₹350 crore per annum. * Furlenco is raising ₹125 crore, in which SFL would be contributing about ₹30 crore to limit dilution. * Amit Kumar Gupta, Group CFO, mentioned that on a consolidated basis, the company grew by around 5% Y-o-Y, from ₹1,622 crore to ₹1,696 crore. * Core EBITDA grew by around 31%, from ₹135 crore to ₹177 crore, resulting in a margin expansion by 210 basis points. * The company reported a PAT of ₹17 crore in H1 FY'26, which includes a one-time impact of MTM on foreign currency and financial investments of ₹18 crore. Normalized PAT stands at around ₹35 crore.

Filing to action

What to do with a filing like this

Sheela Foam Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Sheela Foam Limited. Read the original for the full detail.

View original filing